{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:06:55Z","timestamp":1792210015884,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ahj.2021.01.020","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T14:42:04Z","timestamp":1613918524000},"page":"80-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study"],"prefix":"10.1016","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-735X","authenticated-orcid":false,"given":"W.H. Wilson","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeneng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Tee","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Nieuwdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Matthijs","family":"Boekholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley L.","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2021.01.020_bib0001","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jacc.2019.03.024","article-title":"Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review","volume":"73","author":"Tang","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.01.020_bib0002","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmet.2014.10.006","article-title":"Gamma-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO","volume":"20","author":"Koeth","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.ahj.2021.01.020_bib0003","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.ahj.2021.01.020_bib0004","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.01.020_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2021.01.020_bib0006","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ahj.2021.01.020_bib0007","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.116.025338","article-title":"Gut Microbe-Generated Trimethylamine N-oxide from dietary choline is prothrombotic in subjects","volume":"135","author":"Zhu","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.01.020_bib0008","first-page":"814","article-title":"Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors","volume":"38","author":"Li","year":"2017","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.ahj.2021.01.020_bib0009","first-page":"95","article-title":"EPIC-Norfolk: study design and characteristics of the cohort. European prospective investigation of Cancer","volume":"80","author":"Day","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ahj.2021.01.020_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ab.2014.03.016","article-title":"Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry","volume":"455","author":"Wang","year":"2014","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ahj.2021.01.020_bib0011","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jcmm.13307","article-title":"Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies","volume":"22","author":"Qi","year":"2018","journal-title":"J Cell Mol Med"},{"issue":"39","key":"10.1016\/j.ahj.2021.01.020_bib0012","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/eurheartj\/ehx342","article-title":"Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis","volume":"38","author":"Schiattarella","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.01.020_bib0013","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/heartjnl-2015-308826","article-title":"Trimethylamine N-oxide and prognosis in acute heart failure","volume":"102","author":"Suzuki","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2021.01.020_bib0014","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","article-title":"Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis","volume":"64","author":"Tang","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.01.020_bib0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cardfail.2014.11.006","article-title":"Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure","volume":"21","author":"Tang","year":"2015","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2021.01.020_bib0016","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1681\/ASN.2016030374","article-title":"Trimethylamine N-oxide and cardiovascular events in hemodialysis patients","volume":"28","author":"Shafi","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2021.01.020_bib0017","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1681\/ASN.2014111063","article-title":"Serum Trimethylamine-N-Oxide is Elevated in CKD and correlates with coronary atherosclerosis burden","volume":"27","author":"Stubbs","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2021.01.020_bib0018","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2021.01.020_bib0019","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.kint.2016.01.014","article-title":"Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events","volume":"89","author":"Kim","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2021.01.020_bib0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.atherosclerosis.2016.01.033","article-title":"The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis","volume":"247","author":"Skagen","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2021.01.020_bib0021","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.atherosclerosis.2015.10.091","article-title":"Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control","volume":"243","author":"Mueller","year":"2015","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.ahj.2021.01.020_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004947","article-title":"Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies","volume":"6","author":"Heianza","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.ahj.2021.01.020_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003970","article-title":"Microbiota-dependent metabolite trimethylamine n-oxide and coronary artery calcium in the coronary artery risk development in young adults study (CARDIA)","volume":"5","author":"Meyer","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2021.01.020_bib0024","first-page":"1189","article-title":"The relationship between trimethylamine-n-oxide and prevalent cardiovascular disease in a multiethnic population living in Canada","volume":"31","author":"Mente","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2021.01.020_bib0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.atherosclerosis.2018.11.010","article-title":"Serum gut microbe-dependent trimethylamine N-oxide improves the prediction of future cardiovascular disease in a community-based general population","volume":"280","author":"Zheng","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2021.01.020_bib0026","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","article-title":"High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome","volume":"65","author":"De Filippis","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.ahj.2021.01.020_bib0027","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/eurheartj\/ehy799","article-title":"Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women","volume":"40","author":"Wang","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.01.020_bib0028","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/nu11010179","article-title":"Effects of Lifestyle Intervention on Plasma Trimethylamine N-Oxide in Obese Adults","volume":"11","author":"Erickson","year":"2019","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.ahj.2021.01.020_bib0029","doi-asserted-by":"crossref","first-page":"e00652","DOI":"10.1161\/JAHA.117.006524","article-title":"Plasma metabolites from choline pathway and risk of cardiovascular disease in the PREDIMED (Prevention With Mediterranean Diet) study","volume":"6","author":"Guasch-Ferre","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2021.01.020_bib0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jacc.2019.11.060","article-title":"Long-term changes in gut microbial metabolite trimethylamine n-oxide and coronary heart disease risk","volume":"75","author":"Heianza","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.01.020_bib0031","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ahj.2021.01.020_bib0032","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","article-title":"Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential","volume":"24","author":"Roberts","year":"2018","journal-title":"Nat Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321000570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321000570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:06:55Z","timestamp":1757570815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870321000570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":32,"alternative-id":["S0002870321000570"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2021.01.020","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2021.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}